共 47 条
[22]
Jacobsen HJ., 2015, Pan-HER, an antibody mixture simultaneously targeting EGFR, HER2, and HER3, effectively overcomes tumor heterogeneity and plasticity, V21, P4110, DOI [10.1158/1078-0432.CCR-14-3312, DOI 10.1158/1078-0432.CCR-14-3312]
[23]
Jura N., 2009, Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3, V106, P21608, DOI [10.1073/pnas.0912101106, DOI 10.1073/PNAS.0912101106]
[24]
Kawakami H., 2016, HER3 and its ligand, heregulin, as targets for cancer therapy, V11, P267, DOI [10.2174/1574892811666160418123221, DOI 10.2174/1574892811666160418123221]
[25]
Kumar R., 2020, HER family in cancer progression: From discovery to 2020 and beyond, V147, P109, DOI [10.1016/bs.acr.2020.04.001, DOI 10.1016/BS.ACR.2020.04.001]
[28]
A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma
[J].
BRITISH JOURNAL OF UROLOGY,
1997, 79 (02)
:212-216
[30]
Miller MJ., 2014, HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells, V3, DOI [10.4161/21624011.2014.956012, DOI 10.4161/21624011.2014.956012]